What Is the Tooth Regrowth Pill and How Does It Work?
A tooth regrowth pill is an experimental form of dental regeneration medicine designed to restart natural tooth development in people with missing teeth by reactivating dormant biological pathways responsible for tooth formation. The leading candidate, known as TRG-035, is being tested as a missing teeth treatment that could one day act as an alternative to dentures, implants, and bridges. Humans usually grow two sets of teeth—baby and adult—but researchers think a “hidden” third set may be locked inside inactive tooth buds. TRG-035 targets a protein that works like an off-switch for tooth growth, blocking it so natural signaling can resume. Early animal studies in mice and ferrets showed that a single antibody-based dose could produce fully functional extra teeth without serious safety problems, raising hopes that a pill or injection might trigger similar regrowth in people.
Inside the First Human Trials of Dental Regeneration Medicine
The first human clinical trial of TRG-035 is underway at Kyoto University Hospital, where researchers are testing whether this new dental regeneration medicine is safe. The Phase I study enrolled 30 adult men, each missing at least one tooth, and began in late 2024 with an initial tracking period of 11 months. According to reporting on the trial, “researchers do not expect the adult participants in this early trial to regrow teeth,” because the main aim is to check for side effects, not to restore smiles yet. The pill’s mechanism—blocking a tooth-development “off” protein—was originally identified in genetically modified mice that grew extra teeth when the gene was removed. Later, a single antibody injection produced new, functional teeth in mice and ferrets, encouraging scientists that a similar approach might be safe enough to attempt in humans.
From Dentures to Tooth Regrowth: How This Pill Compares
If future trials succeed, a tooth regrowth pill could become a powerful alternative to dentures and dental implants by solving tooth loss at its biological root. Current options like dentures, bridges, and implants replace missing teeth with artificial materials. They can restore appearance and chewing but may need periodic adjustments, surgery, or maintenance, and they never become living tissue. Regrowing teeth from dormant tooth buds would instead produce natural structures made of real enamel, dentin, and pulp that can potentially grow in harmony with the jaw. As a missing teeth treatment, TRG-035 would not immediately replace every traditional option, especially for complex cases, but it might reduce the need for prosthetic solutions in children and adults who qualify. Over time, combining implants for some patients and regeneration for others could reshape the standard of care in restorative dentistry.
Who Might Benefit First and When Could It Reach Patients?
The developers behind TRG-035 are starting with patients who have the clearest biological need. If safety data from the adult trial remains positive, the next phase will focus on children aged 2 to 7 who were born with missing teeth, particularly those lacking six or more teeth from birth. These cases can affect chewing, speech, jaw growth, and long-term nutrition. Toregem BioPharma has stated that it aims to make the treatment commercially available by 2030 if clinical trials succeed and regulators approve it. Initially, the pill is expected to be offered to children with congenital tooth absence, then later expanded to adults who lost teeth through decay or injury. If those plans stay on track, today’s experimental tooth regrowth pill could, within a few years, move from the lab into dental clinics and begin to change everyday care.
What Tooth Regeneration Could Mean for the Future of Dental Care
Tooth regeneration medicine could transform how dentists think about missing teeth treatment by shifting from replacement to biological repair. Instead of planning around dentures, implants, or bridges, future treatment plans might ask whether a patient’s own tooth buds can be reawakened. For older adults, successful tooth regrowth could improve chewing ability, nutrition, overall health, and quality of life, especially for those who struggle with loose or uncomfortable dentures. For children, early intervention might support better jaw development and reduce the need for complex orthodontics or extensive prosthetic work later in life. Many questions remain—who will respond best, how many teeth can be regrown, and how permanent the results will be—but the early trials of TRG-035 mark a significant step toward a world where growing back missing teeth is a realistic part of mainstream dental care.
